Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Eli Lilly is on a record spending spree, announcing acquisitions worth more than $20 billion so far in 2026 as the drugmaker expands beyond its blockbuster obesity franchise. (Source: Bloomberg)
Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Eli Lilly is on a record spending spree, announcing acquisitions worth more than $20 billion so far in 2026 as the drugmaker expands beyond its blockbuster obesity franchise. (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/3756640dca672d03be4cf33ecef28ef8e0163f40" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Lilly Goes on $20B Buying Spree as It Seeks Next Act"></iframe>
